2725 Fairfield Road
230 articles about Stryker Corporation
SHAREHOLDER ALERT: WeissLaw LLP Investigates Wright Medical Group N.V.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Wright Medical Group N.V. in connection with the proposed acquisition of the Company by Stryker Corporation .
TSO3 Inc. announces receipt of final Court approval for Plan of Arrangement with Stryker
TSO3 Inc. announced that the Superior Court of Québec issued a final order approving the previously-announced statutory plan of arrangement under the Business Corporations Act pursuant to which a wholly-owned subsidiary of Stryker Corporation will acquire all of the issued and outstanding common shares of the Company for CAD$0.43 per share in cash.
K2M GROUP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of K2M Group Holdings, Inc. - KTWO
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of K2M Group Holdings, Inc. ("K2M") (NasdaqGS: KTWO) to Stryker Corporation
Biotech Movers and Shakers Aug. 27
8/27/2018Who made a splash in the biotech world this week? Here are some notable people.
Stryker receives US FDA Pre-market approval for the Surpass Streamline™ Flow Diverter to treat large and giant unruptured aneurysms
Stryker Corporation announced that the U.S. Food and Drug Administration has granted pre-market approval (PMA) for the Surpass Streamline Flow Diverter to treat unruptured large and giant wide neck intracranial aneurysms.
Catalyst OrthoScience Adds Brian K. Hutchison to Board of Directors as Executive Chair, Interim CEO
Catalyst OrthoScience Inc. today announced the addition of Brian K. Hutchison to its board of directors as executive chair.
The device is to be utilized in conjunction with neurovascular embolic coils for the treatment of wide neck, intracranial, saccular aneurysms.
Stryker Corporation Opens New European Headquarters
Osiris Therapeutics, Inc. Enters Exclusive Partnership; Financial Terms Undisclosed
Stryker Corporation Completes Acquisition Of French, German And Asia Pacific Operations Of Small Bone Innovations, Inc.
Most Claims Stand In Zimmer's "Trojan Horse" Lawsuit Against Stryker Corporation , Ex-Sales Rep
Former Sales Rep's Counter-Claims Stand In Poaching Spat With Stryker Corporation
Stryker Corporation Insider Continues Stock Sale By Unloading 7,000 Shares
Mariel Therapeutics Announces Definitive Agreement To Acquire Stryker Corporation 's BMP-7 Assets For Potential Use In Osteoarthritis And Organ Fibrosis
Stryker Corporation To Pay Up To $375 Million For Ankle Replacement Company Small Bone Innovations, Inc.
Stryker Corporation Accuses DePuy Orthopaedics, Inc. Of Raiding California Sales Team
Stryker Corporation Readies $1 Billion Debt Offering
Ex-Stryker Corporation Marketing Executive Escapes Jail Sentence
Ex-Stryker Corporation Exec Dodges Jail In Insider Trading Scheme
Inside Traders Draw Jail Time In Stryker Corporation Case